Gene · 18
Papers2,776
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,776
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome analysis in mice treated with vigabatrin identifies dysregulation of genes associated with retinal signaling circuitry. | Epilepsy Res | 2020 | 32679486 | PubTator, text mining | PubMed |
| Effects of two kinds of fishery drugs on the expressions of GAD and GABA-T mRNA in crucian carp (Carassius auratus gibelio). | Fish Physiol Biochem | 2020 | 32671610 | PubTator, text mining | PubMed |
| The Glutamate System as a Crucial Regulator of CNS Toxicity and Survival of HIV Reservoirs. | Front Cell Infect Microbiol | 2020 | 32670889 | PubTator, text mining | PubMed |
| Drosophila Glia: Models for Human Neurodevelopmental and Neurodegenerative Disorders. | Int J Mol Sci | 2020 | 32660023 | PubTator, text mining | PubMed |
| Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages. | Sci Rep | 2020 | 32616754 | PubTator, text mining | PubMed |
Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells. | Arch Toxicol | 2020 | 32588087 | PubTator, text mining | PubMed |
| Epigenetic Therapies for Osteoarthritis. | Trends Pharmacol Sci | 2020 | 32586653 | PubTator, text mining | PubMed |
| SSADH Variants Increase Susceptibility of U87 Cells to Mitochondrial Pro-Oxidant Insult. | Int J Mol Sci | 2020 | 32575506 | PubTator, text mining | PubMed |
| Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer. | Oncol Lett | 2020 | 32566010 | PubTator, text mining | PubMed |
| Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. | Signal Transduct Target Ther | 2020 | 32555170 | PubTator, text mining | PubMed |
| Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. | Pharmacol Rev | 2020 | 32540959 | PubTator, text mining | PubMed |
| Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies. | Front Oncol | 2020 | 32537435 | PubTator, text mining | PubMed |
| The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma. | Front Oncol | 2020 | 32528886 | PubTator, text mining | PubMed |
| Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy. | Front Physiol | 2020 | 32528308 | PubTator, text mining | PubMed |
| Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer's disease in the offspring hippocampus. | Sci Rep | 2020 | 32528016 | PubTator, text mining | PubMed |
| Functional dissection of gamma-aminobutyric acid metabolism in Neurospora crassa. | Gen Physiol Biophys | 2020 | 32525814 | PubTator, text mining | PubMed |
| Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches. | Contemp Oncol (Pozn) | 2020 | 32514239 | PubTator, text mining | PubMed |
| Identification and validation of prognosis-related DLX5 methylation as an epigenetic driver in myeloid neoplasms. | Clin Transl Med | 2020 | 32508046 | PubTator, text mining | PubMed |
| TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets. | PLoS One | 2020 | 32484822 | PubTator, text mining | PubMed |
| Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid. | Neuroreport | 2020 | 32453018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/18/papers?page=32